84R Stock Overview
An investment holding company, engages in the development and operation of real estate properties in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Glory Health Industry Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.011 |
52 Week High | HK$0.018 |
52 Week Low | HK$0.001 |
Beta | -0.39 |
1 Month Change | 1,000.00% |
3 Month Change | 1,000.00% |
1 Year Change | -21.43% |
3 Year Change | -58.65% |
5 Year Change | n/a |
Change since IPO | -64.52% |
Recent News & Updates
Recent updates
Shareholder Returns
84R | DE Real Estate | DE Market | |
---|---|---|---|
7D | 120.0% | -2.6% | -1.0% |
1Y | -21.4% | 18.7% | 6.4% |
Return vs Industry: 84R underperformed the German Real Estate industry which returned 18.7% over the past year.
Return vs Market: 84R underperformed the German Market which returned 6.4% over the past year.
Price Volatility
84R volatility | |
---|---|
84R Average Weekly Movement | 91.3% |
Real Estate Industry Average Movement | 5.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.7% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 84R's share price has been volatile over the past 3 months.
Volatility Over Time: 84R's weekly volatility has increased from 59% to 91% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 548 | Zhangsun Zhang | www.glorypty.com |
Glory Health Industry Limited, an investment holding company, engages in the development and operation of real estate properties in the People’s Republic of China. The company operates through four segments: Property Development; Primary Land Construction and Development Services; Property Investment; and Property Management and Related Services. The Property Development segment develops and sells commercial and residential properties.
Glory Health Industry Limited Fundamentals Summary
84R fundamental statistics | |
---|---|
Market cap | €73.93m |
Earnings (TTM) | -€71.77m |
Revenue (TTM) | €318.94m |
0.2x
P/S Ratio-1.0x
P/E RatioIs 84R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
84R income statement (TTM) | |
---|---|
Revenue | CN¥2.51b |
Cost of Revenue | CN¥2.56b |
Gross Profit | -CN¥50.28m |
Other Expenses | CN¥513.69m |
Earnings | -CN¥563.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.13 |
Gross Margin | -2.01% |
Net Profit Margin | -22.50% |
Debt/Equity Ratio | 160.9% |
How did 84R perform over the long term?
See historical performance and comparison